Objectives: Despite prevalent b-lactam resistance in Campylobacter jejuni, an important zoonotic enteric pathogen, the molecular basis of b-lactamase-mediated b-lactam resistance is still largely unknown. In particular, some C. jejuni strains that carry b-lactamase gene bla OXA-61 (Cj0299) are still susceptible to b-lactams with undetected b-lactamase activity, suggesting bla OXA-61 is subjected to regulation. The objective of this study was to determine the regulatory mechanism of b-lactamase in C. jejuni.
Introduction b-Lactam antibiotics, which inhibit bacterial cell wall biosynthesis, have been the most commercially available antibiotics in the market because of their high specificity and potent killing effect. By 2010, sales of b-lactam antibiotics accounted for 53% of the total antibiotic market worldwide. 1 However, the emergence of b-lactam-resistant bacteria in the past decades has greatly compromised the clinical effectiveness of b-lactam antibiotics, despite extensive efforts to develop a new generation of b-lactam antibiotics. 2, 3 To develop effective interventions against b-lactam resistance, the underlying resistance mechanisms need to be elucidated.
Several major b-lactam resistance mechanisms have been characterized, including the production of b-lactamases, 4,5 expression of novel penicillin-binding proteins, 6 mutations in porins 7 and production of multidrug efflux pumps. 8 Of these mechanisms, the production of b-lactamases, the enzymes that hydrolyse the b-lactam ring, is still the most widespread and threatening mechanism of antibiotic resistance. 9, 10 In the past, extensive research has focused on the structure, function and ecology of b-lactamases while limited efforts were placed on the regulation of this clinically important enzyme. In Gram-negative bacteria, the expression level of b-lactamases is usually low, but .30 years ago it was observed that b-lactamase production could be regulated. 11 Recently, increasing evidence showed a direct link between b-lactamase production and cell wall metabolism in Gram-negative bacteria. 12 Some genetic mechanisms of b-lactamase regulation also have been identified and proposed, such as the AmpG-AmpR-AmpC pathway. 12 Despite this progress, in-depth knowledge on the genetic mechanism of b-lactamase regulation is still critically needed. 12 Understanding the molecular basis of b-lactamase regulation would facilitate the development of new diagnostic and therapeutic approaches to mitigate b-lactam resistance.
Campylobacter species, including Campylobacter jejuni and Campylobacter coli, are the most common bacterial causes of human gastroenteritis in many industrialized countries. 13 Poultry are the major reservoir of Campylobacter and thus the main source for human campylobacteriosis. 14 In parallel to its increased prevalence, Campylobacter has become increasingly resistant to various antibiotics, particularly fluoroquinolones and macrolides, the two major drugs of choice for treating human campylobacteriosis. 15 Recently, it was proposed that an oral b-lactam, such as co-amoxiclav, may provide an alternative therapy, although epidemiological studies have shown b-lactam resistance to be commonly observed in Campylobacter. 16, 17 Since b-lactams are still not a drug of choice for Campylobacter infections, it is not surprising that a significant knowledge gap still exists concerning the molecular basis of b-lactamasemediated b-lactam resistance in Campylobacter. To date, only one b-lactamase, OXA-61 (Cj0299), has been identified and characterized in C. jejuni. 16, 18 Examination of 1288 Campylobacter isolates with poultry origin showed the presence of bla OXA-61 and the production of b-lactamase were typically associated with resistance to ampicillin and some other b-lactam antibiotics. 16 However, the lack of bla OXA-61 in 9% of ampicillin-resistant (Amp r ) Campylobacter isolates suggested the presence of a novel b-lactamase. 16 On the other hand, 47% of ampicillinsusceptible (Amp s ) Campylobacter isolates carried the bla OXA-61 gene. For example, NCTC 11168, a C. jejuni strain with a published genome, 19 harbours bla OXA-61 but is still susceptible to ampicillin with b-lactamase activity undetected. 16 This finding suggests that production of b-lactamase OXA-61 is probably subjected to regulation by specific trans and/or cis elements.
In this study, the introduction of the ampicillin resistance trait from Amp r C. jejuni 21190 20 to NCTC 11168 prompted us to hunt for novel element(s) involved in b-lactamase-mediated b-lactam resistance by using genome sequencing and comparative genomics analysis. A single nucleotide mutation (G T transversion) was revealed in the bla OXA-61 promoter in the Amp r derivative of NCTC 11168. The role of the G T point mutation in acquired b-lactam resistance by inducing bla OXA-61 expression was confirmed by multiple complementary molecular approaches. The mechanism of this up-regulation was further determined by mapping the transcription start site (TSS), which indicated that the G T transversion restored a complete and functional TATA box in the 210 region of bla OXA-61 .
Methods

Bacterial strains, plasmids and culture conditions
The major bacterial strains and plasmids used in this study are listed in Table 1 . The C. jejuni strains were grown in Mueller-Hinton (MH) broth or on agar at 428C in a tri-gas incubator (85% N 2 /10% CO 2 /5% O 2 ). 
Natural transformation
Natural transformation (biphasic method) was performed following standard procedure as described by Wang and Taylor. 21 Approximately 4 mg of C. jejuni genomic DNA, 1.5 mg of suicide plasmid or 2 mg of PCR product was used for natural transformation. The natural transformation efficiency was expressed as transformants per mg DNA per recipient cfu.
Whole genome sequencing of C. jejuni JL974 C. jejuni JL974 was subjected to 454 GS FLX pyrosequencing as detailed in our recent publication. 22 The generated reads were de novo assembled into contigs using 454 Newbler Assembler software.
Comparative genomics analysis
All assembled contigs were aligned against the reference genome of C. jejuni NCTC 11168 19 by using Mauve (v 2.3.0). 23, 24 Construction of isogenic bla OXA-61 mutants
The bla OXA-61 mutant was constructed by allelic exchange using a suicide plasmid as described previously. 22, 25, 26 Briefly, a 1.5 kb fragment of bla OXA-61 (Cj0299) and its flanking region was PCR amplified from NCTC 11168 using primers Cj0299_F and Cj0299_R ( Table 2 ) and cloned into the pGEM-T-Easy (Promega) vector, resulting in pCj0299-T. The pCj0299-T was digested with HindIII, repaired with T4 DNA polymerase and then ligated with a blunt-ended PCR product containing a chloramphenicol resistance gene, 22 resulting in the suicide plasmid pCj0299(Cm)-T. The orientation of the chloramphenicol resistance gene is the same as that of Cj0299 and was confirmed by PCR using primers Cj0299_F and Cm_Seq_R ( Table 2 ). The suicide plasmid was introduced into NCTC 11168 through natural transformation. A Cm r transformant was selected on an MH plate containing 6 mg/L chloramphenicol and the insertional mutation was confirmed by PCR using primer pairs of Cj0299_F1 and Cj0299_R1 (Table 2 ).
Ampicillin susceptibility testing
The susceptibilities of C. jejuni strains to ampicillin (Fisher Bioreagents) were determined by a standard microtitre broth dilution method with an inoculum of 10 6 cfu/mL as described previously. 20 MICs were determined by the lowest concentration of ampicillin showing complete inhibition of bacterial growth after 2 days of incubation at 428C. Thirty-four C. jejuni isolates from different hosts and geographically diverse areas 26, 27 were subjected to MIC testing.
b-Lactamase activity assay
To qualitatively measure b-lactamase activity in C. jejuni strains, a standard assay was performed by following a previous procedure 16 with minor modifications. Briefly, late-log-phase bacterial cells were harvested from MH plates, washed with PBS and adjusted to an A 600 of 1.2. Bacterial suspensions were sonicated and centrifuged at 13 000 rpm for 5 min. The supernatant was subjected to protein concentration measurement using the BCA Protein Assay Kit (Pierce). One hundred microlitres of supernatant containing 40 mg of protein was mixed with 0.8 mL of ice-chilled reaction buffer (0.1 M phosphate/1 mM EDTA, pH 7.0). Then, 100 mL of nitrocefin (500 mg/L) was added to the above reaction mix followed by incubation at 378C for 30 min. The activity was determined by spectrophotometric change at a wavelength of 486 nm. The molar extinction coefficient of hydrolysed nitrocefin at 486 nm is 20 500 M 21 cm 21 . The lysate from C. jejuni 81-176, a strain lacking bla OXA-61 and b-lactamase activity, 16 was used as a negative control.
Complementation of C. jejuni 81-176 with bla OXA-61
The full length of bla OXA-61 and its upstream promoter region was amplified from NCTC 11168 and its Amp r derivative JL974, respectively, using primer pairs of Cj0299_F and Cj0299_R (Table 2) with PfuUltra II Fusion DNA Polymerase (Stratagene). The resulting 1.5 kb fragment was ligated into SmaI-digested shuttle vector pRY107 28 and the ligation mix was introduced into E. coli DH5a by heat-shock transformation. The E. coli transformants containing the plasmid that bears wild-type bla OXA-61 (named pCj0299 11168 ) or the plasmid that bears the G T transversion in the promoter of bla OXA-61 (named pCj0299 JL974 ) were identified. Both pCj0299 11168 and pCj0299 JL974 were confirmed by sequencing and then mobilized into C. jejuni 81-176 by triparental conjugation as described previously. 22 Promoter fusion construction and b-galactosidase (LacZ) assay A 280 bp DNA fragment containing the promoter region of bla OXA-61 was amplified from wild-type NCTC 11168 with primer pair Cj0299_pMW10_F and Cj0299_pMW10_R1 ( Table 2 ). The amplified PCR products were digested with BamHI and XbaI and then ligated into BamHI/ XbaI-digested plasmid pMW10, a shuttle vector carrying a promoterless lacZ gene, 29 leading to the reporter construct pMW10 11168 ( Table 1) . The same promoter region in JL974 that contains G T transversion was also PCR amplified and inserted into pMW10, creating plasmid pMW JL974 ( Table 1 ). The reporter constructs pMW10 11168 and pMW JL974 were conjugatively transferred into C. jejuni 81-176 and the LacZ activity of the Campylobacter constructs was measured as described previously. 30 All assays were performed in triplicate.
Overlapping PCR and construction of genetically defined mutants
Overlapping PCR was performed to introduce the G T point mutation into a 1.5 kb fragment that covers the bla OXA-61 (Cj0299) promoter region. Briefly, Cj0299_F and Cj0299_R3 (Table 2 ) were used to amplify the upstream region of bla OXA-61 with PfuUltra II Fusion DNA Polymerase (Stratagene), while Cj0299_F3 and Cj0299_R (Table 2 ) were used to amplify a downstream fragment. The upstream and downstream fragments were purified from agarose gel, mixed at equal molar ratio and used as template for the second-round PCR using primer Cj0299_F and Cj0299_R. The desired 1.5 kb overlapping PCR product was purified using the QIAquick PCR Purification Kit (Qiagen). This overlapping PCR fragment shares identical sequence to the corresponding region in NCTC 11168 except the G T point mutation, which was confirmed by sequencing. This defined PCR product was used to transform NCTC 11168 via natural transformation. Amp r transformants were selected on MH plates supplemented with 100 mg/L ampicillin. Three Amp r colonies were randomly selected and subjected to MIC testing and molecular analysis. Specifically, the bla OXA-61 gene and its promoter region in these three transformants were PCR amplified and fully sequenced to confirm the presence of the G T point mutation in the promoter region.
RNA extraction
C. jejuni were grown on MH plates for 16 h and harvested using MH broth with a final A 600 of 1.2. One millilitre of RNAprotect Bacteria Reagent (Qiagen) was added immediately into 0.5 mL of bacterial suspension. Bacteria were pelleted and total RNAs were extracted using the RNeasy Mini Kit (Qiagen). Residual genomic DNA was removed through DNase I (New England Biolabs) treatment. These total RNAs were used for 5 ′ -RACE (rapid amplification of cDNA ends) and real-time RT-PCR analysis as described below.
Mapping of TSS
The mapping of TSS of bla OXA-61 was performed using Invitrogen's 5 ′ -RACE system as described by Filiatrault et al. 31 Briefly, 3 mg of total RNA was used to synthesize the first strand of cDNA with primer Cj0299_R1 ( Table 2 ). The cDNAs were subsequently purified through the SNAP column supplied in the kit. Ten microlitres of the purified cDNA was then subjected to terminal deoxynucleotidyl transferase (TdT) tailing and PCR purification using the Abridged Anchor Primer (supplied within the kit) and Cj0299_R4
( Table 2 ). The PCR products were separated in 0.8% agarose by electrophoresis. Bands were purified from the gel and cloned into pGEM-T-easy vector (Promega). The plasmids from positive clones were sequenced for determination of TSS.
Real-time RT-PCR
Real-time quantitative RT-PCR was performed by following the procedure detailed in our previous publication. 32 Triplicate reactions in a volume of 20 mL were performed for each RNA sample. The difference in bla OXA-61 transcription between NCTC 11168 and its Amp r derivative JL974 were calculated using the 2 2DDCT method as described previously. 32 Expression of 16S ribosomal RNA was used as an internal control.
Nucleotide sequence accession number
The whole genome shotgun project of the Amp r derivative of NCTC 11168 (JL974) has been deposited at DDBJ/EMBL/GenBank under the BioProject PRJNA216960.
Results
Generation of an Amp r derivative of C. jejuni NCTC 11168
An Amp r C. jejuni 21190 that produces b-lactamase was used in our previous study. 20 Using NCTC 11168 as a recipient strain, in this study, Amp r transformants could be easily obtained via natural transformation by using the purified genomic DNA from C. jejuni 21190; the natural transformation frequency is as high as 4×10 25 colonies/mg DNA/recipient. One Amp r transformant was randomly selected and named as JL974 (Table 1 ). JL974 and its parent strain NCTC 11168 displayed significantly different susceptibilities to ampicillin, with MICs of 256 and 16 mg/L, respectively ( Table 3 ). The b-lactamase activity assay confirmed that NCTC 11168 only displayed marginal nitrocefin-hydrolysing activity (284+5 mmol/h/mg) ( Figure 1a ). In contrast, both JL974 and C. jejuni 21190 displayed significantly enhanced nitrocefinhydrolysing activity (2901+40 and 2818+15 mmol/h/mg, respectively) ( Figure 1a) . Given that the genetic basis of the highlevel b-lactamase activity in C. jejuni 21190 was not clear, the acquired high-level b-lactam resistance in JL974 could be due 
Genome sequencing and comparative genomics analysis
Since the genome sequence of NCTC 11168 has been published, 19 it was feasible for us to determine the molecular basis of b-lactamase-mediated b-lactam resistance in JL974 using comparative genomics analysis. The JL974 was subjected to 454 GS FLX pyrosequencing and the sequencing result is summarized in Table S1 (available as Supplementary data at JAC Online). De novo assembled contigs were aligned against the NCTC 11168 genome using Mauve ( Figure S1 , available as Supplementary data at JAC Online). Examination of the potential insertions and deletions (InDels) indicated all the InDels were artefacts due to the inability of software to align all the contigs appropriately. After analysing the unordered JL974 contigs ( Figure S1 , available as Supplementary data at JAC Online), we ruled out the possibility that a certain DNA fragment was inserted or deleted in the genome of JL974. This suggested that the changes in JL974 may occur in the existing gene and/or in the intergenic region at the nucleotide level. We then focused on the sequence of the sole b-lactamase gene bla OXA-61 present in NCTC 11168. 16 As shown in Figure S1 , available as Supplementary data at JAC Online, there is no mutation identified in the coding sequence of bla OXA-61 . The G T transversion in the promoter region (57 bp upstream of the annotated start codon) was the only mutation identified. Based on this finding, we speculated that the G T transversion resulted in the sustained high-level production of b-lactamase OXA-61, consequently leading to enhanced resistance to ampicillin in JL974.
bla OXA-61 is essential for the acquired ampicillin resistance Prior to examining the specific role of G T transversion in bla OXA-61 -mediated ampicillin resistance, genetic evidence is needed to confirm that bla OXA-61 is a key player in the acquired ampicillin resistance in JL974. Thus, an isogenic bla OXA-61 mutant of NCTC 11168 was constructed and then an insertional mutation of bla OXA-61 was transferred to JL974. As shown in Table 3 , inactivation of bla OXA-61 in both NCTC 11168 and JL974 led to a significantly reduced MIC of ampicillin, indicating bla OXA-61 is responsible for both intrinsic and high-level ampicillin resistance. Real-time RT -PCR analysis further showed that the mRNA level of bla OXA-61 in JL974 was dramatically increased 239-fold (DDCT¼7.9) when compared with that in NCTC 11168. Together, these mutational and transcriptional analyses demonstrated that the enhanced ampicillin resistance in JL974 was due to the up-regulation of b-lactamase OXA-61.
The G T point mutation induced bla OXA-61 and conferred high-level ampicillin resistance in C. jejuni 81-176 C. jejuni 81-176 is an Amp s strain that lacks the bla OXA-61 gene. 16, 25 Therefore, C. jejuni 81-176 serves as an ideal host to study the role of the specific G T point mutation in the induction of bla OXA-61 and ampicillin resistance using a complementation approach. The bla OXA-61 gene and its promoter region were PCR amplified from NCTC 11168 and JL974, respectively, and subsequently cloned into a shuttle vector; the sequences of the two PCR fragments were identical except the G T point mutation (data not shown). As shown in Table 3 , the plasmid containing fragment from wild-type NCTC 11168 (pCj0299 11168 ) slightly increased MIC of 81-176 for ampicillin (4-fold) while the plasmid containing the PCR fragment from JL974 (pCj0299 JL974 ) led to drastically increased MIC for ampicillin (256-fold). Consistent with the MIC result, pCj0299 JL974 conferred 81-176 significantly increased b-lactamase activity (4564+19 mmol/h/mg) when compared with pCj0299 11168 (241+41 mmol/h/mg) (Figure 1b ). This finding indicated that the single G T point mutation led to enhanced production of OXA-61 as well as high-level ampicillin resistance. 
Campylobacter b-lactamase regulation
To examine the effect of the G T mutation on bla OXA-61 expression at the transcriptional level, LacZ transcription fusions containing the specific promoter region were constructed and transferred to C. jejuni 81-176 for LacZ activity measurement. As expected, the strain containing the mutated promoter (81-176/pMW10 JL974 ) displayed 15-fold higher LacZ activity than the strain containing the original promoter (81-176/ pMW10 11168 ) (Figure 1c ).
Construction of the genetically defined G T point mutation in the chromosome
JL974 was constructed through natural transformation using genomic DNA of C. jejuni 21190. Thus, compared with its parent strain NCTC 11168, JL974 probably contains point mutations from 21190 in addition to the G T mutation, which may cause background noise for comparing the phenotype between JL974 and NCTC 11168. To definitively link the G T point mutation to the enhanced OXA-61 production and corresponding high-level ampicillin resistance, we generated a defined 1.5 kb PCR fragment to transform NCTC 11168 via natural transformation; this 1.5 kb PCR fragment covers the bla OXA-61 promoter and is identical to its corresponding sequence in NCTC 11168 except the G T point mutation. Three Amp r transformants were randomly selected. The bla OXA-61 promoter region of each Amp r transformant was PCR amplified and sequenced, which showed that all the three transformants contain the G T transversion (data not shown). The three Amp r transformants (named 11168 G T ) displayed the same high-level ampicillin resistance as JL974 ( Table 3) ; inactivation of bla OXA-61 in 11168 G T also led to a dramatically reduced MIC (64-fold reduction). Together, the construction of a genetically defined G T point mutation in the chromosome further demonstrated that this unique mutation could result in acquired high-level ampicillin resistance in C. jejuni.
Presence of the G T transversion and high-level ampicillin resistance in C. jejuni isolates
Of the 34 C. jejuni isolates tested, 32 displayed a low-level MIC of ampicillin (ranging from 1 to 16 mg/L). In addition to 21190, one isolate, named JL115, also displayed high-level resistance to ampicillin (MIC ¼ 256 mg/L) ( Table 4 ). The promoter region of bla OXA-61 was PCR amplified from five isolates with a low-level MIC (81116, S3B, JL95, JL98 and JL100) and two Amp r isolates (JL115 and 21190). Sequencing analysis showed all the strains that lack the G T transversion in the bla OXA-61 promoter displayed a low-level MIC of ampicillin (Table 4 ). In contrast, the two Amp r isolates, JL115 and 21190, harboured the G T transversion in the promoter of bla OXA-61 . As expected, inactivation of bla OXA-61 in these two Amp r isolates also dramatically reduced the ampicillin MIC and b-lactamase activity to similar levels as those of the isogenic bla OXA-61 mutant of NCTC 11168 (data not shown). We also examined 41 published C. jejuni genomes and observed that four strains contain the same G T transversion in the promoter of bla OXA-61 (Table S2 , available as Supplementary data at JAC Online).
The G T transversion restored the TATA box in the promoter region of bla To examine how G T transversion affects bla OXA-61 transcription, the TSS of bla OXA-61 was mapped using the 5 ′ -RACE approach. 31 As shown in Figure 2 (a), only a short band ( 200 bp) was observed for wild-type NCTC 11168. However, all the three Amp r C. jejuni strains (JL974, 21190 and JL115) that harbour the G T transversion displayed two bands, with size 200 and 340 bp, respectively (Figure 2a ). This finding suggests that the G T transversion creates another TSS for bla OXA-61 , leading to a long transcript in addition to the short transcript observed in NCTC 11168. To test this, both bands were cloned for sequencing analysis, which revealed the accurate position of the two TSS (Figure 2b) . Surprisingly, the sole TSS for NCTC 11168 was in fact 94 bp downstream of the annotated start codon ATG (named '2nd TSS' in Figure 2b ). However, the other TSS (named '1st TSS' in Figure 2b ), which was identified by the sequence of long band, starts from 46 bp upstream of the predicted start codon of bla OXA-61 . As show in Figure 2(b) , the G T transversion is located in the 210 region of the first TSS. This point mutation changed the TATA box sequence from GAAAAT to TAAAAT.
Discussion
The bla OXA-61 gene appears to be 'cryptic' in many C. jejuni isolates that displayed low or no b-lactamase activity according to the The existence of bla OXA-61 was based on PCR using the specific primer pair Cj0299_F1 and Cj0299_R1 ( Table 2 ).
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survey in this study, which is consistent with the observation by Griggs et al. 16 This phenomenon was also observed in Amp s E. coli K12 strain, which harbours a 'cryptic' b-lactamase gene ampC in the chromosome. 33 However, two Amp r derivatives of E. coli K12 were selected through stepwise selection: one mutant has a single base insertion before the 210 region while another harbours a single C A transversion (37 bp downstream of TSS). 33 The C A transversion was proposed to destabilize the stem pairing of an attenuator, thus increasing the expression of ampC in E. coli. 33 In our study here, the G T transversion in bla OXA-61 was mapped to the 210 region of the normal bla OXA-61 transcript (Figure 2b) . Given its unique position, the G T point mutation may affect the affinity of the promoter region for RNA polymerase, instead of destabilizing the attenuator-like structure as proposed in E. coli. 33 Specifically, it is likely that this G T transversion restores the TATA box-from GAAAAT to TAAAAT-and makes the TATA box fully functional in C. jejuni. The TAAAAT sequence has been identified in the promoter region of various C. jejuni genes. 29 Notably, a recent high-resolution transcriptome mapping study 34 also showed the TAAAAT sequence is part of the Campylobacter b-lactamase regulation extended 210 box [(T/A)(G/A)xTA(T/A)AAT] in the upstream region of a majority of TSS in C. jejuni. In addition, these high-throughput RNA sequencing data also show that bla OXA-61 could be transcribed from either the 246 or the +96 bp site relative to the annotated start codon, 34 which is the same as what we observed in this study (Figure 2b) . Clearly, the long transcript starting from the 246 bp site would result in the full-length bla OXA-61 as annotated. The short transcript starting from +96 bp would lead to a truncated form of OXA-61, which may not function properly, either due to impaired b-lactamase function or an inability to translocate to the periplasm. In this study, 34 C. jejuni isolates from different hosts and geographically diverse areas were examined for the relationship between ampicillin susceptibilities and the presence of the G T transversion. We observed that only Amp r isolates contain the G T transversion in the bla OXA-61 promoter. Notably, the b-lactamase OXA-61 was first identified in an Amp r C. jejuni by Alfredson and Korolik, 18 which also possesses the same G T transversion (GenBank accession number AY587956). However, in a recent study, 16 examination of 10 b-lactamase-producing poultry isolates did not reveal the specific G T point mutation in the promoter of bla OXA-61 . It is likely that other mechanisms contribute to the ampicillin resistance in these C. jejuni isolates, such as the presence of a novel b-lactamase as proposed by the investigators. 16 However, given the evidence shown in this study, future large-scale surveys of the relationship between the presence of the G T transversion and bla OXA-61 -mediated highlevel b-lactam resistance in diverse C. jejuni isolates are highly warranted. In addition, because the 'cryptic' nature of bla OXA-61 was also observed in C. coli isolates, 35 an in-depth epidemiological examination of bla OXA-61 in C. coli would provide insights into the regulation and evolution of b-lactam resistance in Campylobacter. It may lead to novel diagnostics for the identification of b-lactam-resistant Campylobacter, particularly with the recent trend to use new-generation high-throughput sequencing for clinical diagnosis. 35, 36 
